-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Navidea Biopharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2011 to Q1 2023.
- Navidea Biopharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2023 was -$39.4K, a 66.7% increase year-over-year.
- Navidea Biopharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$390K, a 18.5% decline from 2021.
- Navidea Biopharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$329K, a 20.2% increase from 2020.
- Navidea Biopharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$413K, a 154% decline from 2019.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)